by Rawamino | Oct 28, 2025 | Peptides
Introduction Protein misfolding and aggregation are central pathological features in neurodegenerative disorders, contributing to cellular toxicity, synaptic loss, and chronic neuroinflammation. Experimental models of Alzheimer’s disease (AD) and Parkinson’s disease...
by Rawamino | Oct 28, 2025 | Peptides
Introduction Parkinson’s disease (PD) is characterized by progressive degeneration of midbrain dopaminergic neurons and the emergence of motor and non-motor features that substantially impair function. Converging evidence suggests a multifactorial etiology in which...
by Rawamino | Oct 27, 2025 | Peptides
Introduction Neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) emerge from intersecting processes—proteostasis failure, maladaptive stress signaling, metabolic compromise, and inflammation—that culminate in progressive neuronal...
by Rawamino | Oct 27, 2025 | Peptides
Introduction The formation and accumulation of misfolded protein aggregates—such as β-amyloid (Aβ) plaques and α-synuclein fibrils—represent central hallmarks of Alzheimer’s disease (AD) and Parkinson’s disease (PD). However, mounting evidence suggests that smaller,...
by Rawamino | Oct 27, 2025 | Peptides
Introduction Glucagon-like peptide-1 (GLP-1) is an intestinally derived peptide hormone that links nutrient sensing in the gut to coordinated metabolic responses across the pancreas, liver, brain, and gastrointestinal tract. As an incretin, GLP-1 enhances...
by Rawamino | Oct 27, 2025 | Peptides
Introduction Hair loss (alopecia) is a multifactorial biological process influenced by genetic predisposition, endocrine signaling, immune tone, microvascular supply, and local tissue repair pathways. Over the past decade, advances in skin biology have reframed the...
